Ionizing radiation-induced bystander mutagenesis and adaptation: quantitative and temporal aspects.
This work explores several quantitative aspects of radiation-induced bystander mutagenesis in WTK1 human lymphoblast cells. Gamma-irradiation of cells was used to generate conditioned medium containing bystander signals, and that medium was transferred onto naïve recipient cells. Kinetic studies revealed that it required up to 1h to generate sufficient signal to induce the maximal level of mutations at the thymidine kinase locus in the bystander cells receiving the conditioned medium. Furthermore, it required at least 1h of exposure to the signal in the bystander cells to induce mutations. Bystander signal was fairly stable in the medium, requiring 12-24h to diminish. Medium that contained bystander signal was rendered ineffective by a 4-fold dilution; in contrast a greater than 20-fold decrease in the cell number irradiated to generate a bystander signal was needed to eliminate bystander-induced mutagenesis. This suggested some sort of feedback inhibition by bystander signal that prevented the signaling cells from releasing more signal. Finally, an ionizing radiation-induced adaptive response was shown to be effective in reducing bystander mutagenesis; in addition, low levels of exposure to bystander signal in the transferred medium induced adaptation that was effective in reducing mutations induced by subsequent gamma-ray exposures.
Zhang
Ying
Y
Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, CO 80523, USA.
Zhou
Junqing
J
Baldwin
Joseph
J
Held
Kathryn D
KD
Prise
Kevin M
KM
Redmond
Robert W
RW
Liber
Howard L
HL
D000222:Adaptation, Physiological; D024201:Bystander Effect; D002460:Cell Line; D005720:Gamma Rays; D006801:Humans; D007700:Kinetics; D016296:Mutagenesis; D013997:Time Factors
Int J Radiat Biol. 2004 Jul;80(7):465-72
15360084
Radiat Res. 2002 Nov;158(5):626-33
12385640
Radiat Res. 2007 Sep;168(3):292-8
17705636
Radiat Res. 2001 Mar;155(3):397-401
11182789
Environ Health Perspect. 1994 Dec;102 Suppl 10:25-8
7705299
J Pharm Pharmacol. 2008 Aug;60(8):943-50
18644187
Oncogene. 2005 Mar 17;24(12):2096-103
15688009
Radiat Res. 2008 Feb;169(2):197-206
18220473
Radiat Res. 1998 Nov;150(5):497-504
9806590
Radiat Res. 2005 Oct;164(4 Pt 1):369-82
16187739
Mutat Res. 2002 Jun 19;503(1-2):1-9
12052498
Int J Radiat Biol. 1997 Apr;71(4):421-7
9154145
Int J Radiat Biol. 2003 Jan;79(1):35-41
12556329
Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2099-104
10681418
Environ Health Perspect. 1993 Oct;101 Suppl 3:73-7
8143650
Hum Exp Toxicol. 1999 Jul;18(7):440-2
10454074
Int J Radiat Biol. 1997 Mar;71(3):245-52
9134013
Environ Health Perspect. 1998 Feb;106 Suppl 1:277-83
9539019
Radiat Res. 2005 Aug;164(2):141-7
16038585
Folia Biol (Praha). 1997;43(2):91-5
9158957
Mutat Res. 2002 Aug 26;519(1-2):15-24
12160888
Mutat Res. 2004 Dec 2;568(1):121-8
15530545
Oncogene. 2003 Oct 13;22(45):7058-69
14557811
Dose Response. 2006 Aug 25;4(4):283-90
18648593
Radiat Res. 2001 Feb;155(2):335-44
11175669
Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):550-6
15979669
Int J Radiat Biol. 2006 Aug;82(8):537-48
16966181
Cancer Res. 2008 Sep 1;68(17):7059-65
18757420
Hum Exp Toxicol. 1999 Jul;18(7):447-51
10454076
Br J Cancer. 2009 Jun 16;100(12):1912-6
19455142
Oncogene. 2007 Feb 15;26(7):993-1002
16909103
Mutat Res. 1993 Apr;286(2):233-41
7681535
Radiat Res. 2001 Jun;155(6):759-67
11352757
Radiat Res. 2007 Apr;167(4):485-92
17388689
Radiat Environ Biophys. 2007 Mar;46(1):1-12
17131131
Int J Radiat Biol. 2007 Mar;83(3):153-9
17378523
Radiat Res. 2001 Aug;156(2):177-80
11448238
Mutat Res. 1993 Feb;301(2):135-41
7678171
Mutat Res. 2004 Dec 2;568(1):21-32
15530536
Science. 1984 Feb 10;223(4636):594-7
6695170
Cancer Res. 1992 Nov 15;52(22):6394-6
1423287
Cell Cycle. 2007 Sep 15;6(18):2210-2
17881892
Mutat Res. 2009 Jun 18;666(1-2):68-73
19393669
Oncogene. 2003 Oct 13;22(45):6978-87
14557801
Mutat Res. 2004 Dec 2;568(1):79-87
15530541
Radiat Res. 2006 Jan;165(1):26-34
16392959
Oncogene. 2003 Oct 13;22(45):7050-7
14557810
Radiat Res. 2003 Nov;160(5):512-6
14565832
Cancer Res. 2008 Apr 1;68(7):2233-40
18381429
Anal Biochem. 1981 Jan 1;110(1):1-8
7011090
Mutat Res. 2002 Jul 25;504(1-2):101-18
12106651
Oncogene. 2003 Oct 13;22(45):7094-9
14557815
Mutat Res. 1995 Sep;348(1):45-50
7565914
Hum Exp Toxicol. 1999 Jul;18(7):443-6
10454075
Cancer Res. 2007 Jun 15;67(12):5872-9
17575156
Br J Cancer. 2008 Jun 3;98(11):1839-44
18475304
Cancer Res. 2002 Oct 1;62(19):5436-42
12359750
Mutat Res. 2002 Oct 31;508(1-2):121-9
12379467
Int J Radiat Biol. 2007 Feb;83(2):73-80
17357428